Kythera shares climb in Nasdaq trading debut

Published



Kythera Biopharmaceuticals shares are trading above their offering price in their first day listed on the Nasdaq Stock Market.

The stock jumped 81 cents, or 4.4 percent, to $19.30 in late morning trading, and earlier traded as high as $20.59.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.